Skip to content

Intervention study of Baduanjin on blood pressure and intestinal flora in middle-aged and elderly patients with hypertension

Intervention study of Baduanjin on blood pressure and intestinal flora in middle-aged and elderly patients with hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024429
Enrollment
Unknown
Registered
2019-07-11
Start date
2020-12-06
Completion date
Unknown
Last updated
2020-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Male or female,between the age of 45-80years; (2) Office blood pressure :120SBP <= 140mmHg,DBP < 90mmHg (according to baseline screened measurement -office blood presure will be measured in a standardized fashion); (3) Stable dose of antihypertensive drugs for at least 3 months ; (4) Treated with moderate dose of two or more antihypertensive drugs for at least 12 months.According to the guidelines,antihypertensive drugs are defined as any ACE inhibitor,angiotensinII recepor blocker,calcium channel blocker,thiazide and thiazide-like diuretic,potassium-sparing diuretic,beta-blocker,vasodilator antihypertensives,centrally acting antihypertensives,direct renin inhibitors,adrenergic neuron blocking drugs or loop diuretics; (5) Eligible patients will be willing to particpate the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Secondary hypertension or previous diagnosed resistant hypertension; (2) Serious cardiovascular system,pulmonary system,liver,kidney system and nervous sysytem disease,psychiatric disorders,cancer,infectious diseases or others,limiting ability to participate in the Baduanjin or aerobic exercise programs and influencing reduction or discontinuation of antihypertensive drugs; (3) Using other drugs that may sffect blood presure; (4) Smoking and/or alcohol abuse; (5) Pregnancy or women who are planning to be pregnant; (6) Enrolled in other clinical trials in the last 3 months; (7) Practiced Baduanjin or other similar types of physical activities in the past 3 months,such as Qi Gong,yoga and Tai Chi; (8) Taken antibiotics,probiotics or yogurt within latst 1 month.

Design outcomes

Primary

MeasureTime frame
Withdrawal rate of antihypertensive drugs;

Secondary

MeasureTime frame
24-hour ambulatory blood pressure mean change and blood pressure variability;Office blood pressure;Quantitative grading of symptoms of hypertension;Blood sugar and blood lipid levels;Quality of Life Scale (SF-36);Changes in gut microbial composition;

Countries

China

Contacts

Public ContactWu Min

Guang'anmen Hospital, China Academy of Chinese Medical Science

wumin19762000@126.com+86 13671206090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026